-
Mashup Score: 4
At Ochre Bio, we’re developing therapies for the biggest liver health challenges, from increasing donor liver supply to reducing cirrhosis complications.
Source: www.ochre-bio.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12Boehringer Ingelheim strong growth pipeline acceleration 2023 | Boehringer Ingelheim - 14 day(s) ago
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12
SPEVIGO® approved for expanded indications in China and the US
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 25
Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 65survodutide top-line results MASH fibrosis | Boehringer Ingelheim - 2 month(s) ago
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 65survodutide top-line results MASH fibrosis | Boehringer Ingelheim - 2 month(s) ago
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 65survodutide top-line results MASH fibrosis | Boehringer Ingelheim - 2 month(s) ago
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 10
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 23Boehringer expands production site in Greece | Boehringer Ingelheim - 4 month(s) ago
Boehringer expands production site in Greece for new medicine
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5
The ADVANCE study will be the most detailed observational study of its kind providing a detailed analysis of liver health.
Source: www.boehringer-ingelheim.comCategories: General Medicine News, PayerTweet
#NEWS: Announcing our new partnership with @OchreBio to develop novel regenerative treatments for patients with advanced liver disease, including metabolic associated steatohepatitis (#MASH) cirrhosis. Learn more: https://t.co/UcaX21LCLm #LiverDisease #ResearchAndDevelopment https://t.co/0M7uWINnGc